Cargando…

Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up

BACKGROUND: Genetic variants of outer dynein arm docking complex subunit 2 (ODAD2) have been reported to be closely associated with primary ciliary dyskinesia and colorectal cancer in previous studies, but the association of genetic variants of ODAD2 with hepatocellular carcinoma (HCC) has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Zhiming, Liao, Xiwen, Huang, Ketuan, Han, Chuangye, Qin, Wei, Su, Hao, Ye, Xinping, Yang, Chengkun, Zhou, Xin, Wei, Yongguang, Mo, Shutian, Liu, Junqi, Lan, Chenlu, Huang, Xinlei, Huang, Zaida, Peng, Kai, Gao, Qiang, Peng, Tao, Zhu, Guangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571289/ https://www.ncbi.nlm.nih.gov/pubmed/37833735 http://dx.doi.org/10.1186/s12957-023-03205-4

Ejemplares similares

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023)

Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
por: Huang, Huasheng, et al.
Publicado: (2022)

Intraoperative Indocyanine Green Retention Test of Left Hemiliver in Decision-Making for Patients With Hepatocellular Carcinoma Undergoing Right Hepatectomy
por: Yu, Tingdong, et al.
Publicado: (2021)

Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023)

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2018)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Identification of prognostic biomarkers for patients withhepatocellular carcinoma after hepatectomy
por: Wang, Xiangkun, et al.
Publicado: (2019)

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus-related hepatocellular carcinoma
por: Zhou, Xin, et al.
Publicado: (2019)

Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy
por: Liao, Xiwen, et al.
Publicado: (2017)

Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi
por: Su, Hao, et al.
Publicado: (2021)

Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus-associated hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Laparoscopic versus open hepatectomy for hepatocellular carcinoma with cirrhosis: a single-center propensity score matching analysis
por: He, Yongfei, et al.
Publicado: (2021)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
por: Wu, Yining, et al.
Publicado: (2023)

Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus-related hepatocellular carcinoma
por: Han, Quanfa, et al.
Publicado: (2019)

RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
por: Wei, Yongguang, et al.
Publicado: (2023)

Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome–Wide Association Study
por: Yang, Chengkun, et al.
Publicado: (2018)

Genome-wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein-coding genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Genetic variants and Expression of Cytochrome p450 Oxidoreductase Predict Postoperative Survival in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Huang, Ketuan, et al.
Publicado: (2019)

Correlation between ABO blood group and prognosis of hepatectomy for hepatitis B virus-associated hepatocellular carcinoma
por: Liao, Yuan, et al.
Publicado: (2023)

ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma
por: Zhu, Guangzhi, et al.
Publicado: (2017)

Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model
por: He, Yongfei, et al.
Publicado: (2022)

UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2021)

Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Xiaoguang, et al.
Publicado: (2018)

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)

Clinical significance and prospective molecular mechanism of C-C motif chemokine receptors in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Zhou, Xin, et al.
Publicado: (2019)

Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China
por: Qin, Wei, et al.
Publicado: (2020)

Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus‐related hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2017)

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023)

Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
por: Yang, Chengkun, et al.
Publicado: (2018)

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u21f67rjkelka251nms5gptc5e